Skip to content
Trial Master File Reference Model Discussion Forum
Trial Master File Reference Model Discussion Forum

(a Community Group now part of CDISC)

  • Home
  • Forums
  • Login
  • Subscribe
Trial Master File Reference Model Discussion Forum
Trial Master File Reference Model Discussion Forum

(a Community Group now part of CDISC)

  • Home
  • Forums
  • Login
  • Subscribe

Home › Forums › Signatures › FDA Provides Clarification on 21CFR11 for Third Parties › Reply To: FDA Provides Clarification on 21CFR11 for Third Parties

August 1, 2021 at 7:44 am #4227
Mai NishiharaMai Nishihara
Participant

Dear Eldin

Thank you for posting the document.
Watching your session online, I looked forward to having some guidance from FDA.
The attached email you shared really helps me to get a clear picture.

Warm Regards
Mai

Post navigation
Next Reply →

Recent Discussion Topics

  • Question on Filing EDC Raw Datasets/Vendor Data in TMF
    2 months ago
  • Third Parties Invoices
    3 months ago
  • data privacy notice signed by site personnel
    3 months, 2 weeks ago

Copyright © 2026 Trial Master File Reference Model Discussion Forum | Powered by Astra WordPress Theme